Parkside Financial Bank & Trust Uni Qure N.V. Transaction History

Parkside Financial Bank & Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$18.7 - $23.07 $2,449 - $3,022	-131 Reduced 50.19%	130 $2,000
Q3 2022 Nov 01, 2022	BUY	$16.98 - $25.54 $2,105 - $3,166	124 Added 90.51%	261 $4,000
Q2 2022 Jul 13, 2022	BUY	$13.15 - $20.45 $78 - $122	6 Added 4.58%	137 $2,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $3,116 - $5,545	-154 Reduced 54.04%	131 $3,000
Q3 2021 Oct 29, 2021	BUY	$26.01 - $38.22 $4,005 - $5,885	154 Added 117.56%	285 $9,000
Q1 2021 May 10, 2021	BUY	$29.24 - $42.03 $3,830 - $5,505	131 New	131 $4,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.